Impact of vancomycin therapeutic drug monitoring on mortality in sepsis patients across different age groups: a propensity score-matched retrospective cohort study
Vancomycin TDM is associated with reduced 30-day mortality in sepsis patients, with the most significant benefit observed in patients aged 18-50. This age group exhibited the lowest mortality rates and experienced the greatest reduction in mortality following TDM compared with older patients.
Authors
- Qilin Yang (ORCID: https://orcid.org/0000-0002-5435-8839)
- Ruolun Wang
- Huaidong Peng (ORCID: https://orcid.org/0000-0003-1817-516X)
- Ruichang Zhang (ORCID: https://orcid.org/0000-0001-8174-9432)
- Tingting Xu (ORCID: https://orcid.org/0009-0003-6520-4979)
- Sijie Zhou (ORCID: https://orcid.org/0000-0001-8968-5736)
- Xunlong Zhong
- Xiaorui Liu
Institutions
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Twelfth Guangzhou City People's Hospital (CN)
- Guangzhou Medical University Cancer Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-12-12
- DOI
- https://doi.org/10.3389/fmed.2024.1498337
- Citations
- 2
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77